Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
11:39a UTTARA FINANCE AND INVESTMENTS : Banks to remain closed in Dhaka, Ctg on April 28 for polls
11:38a ASR LOGISTICS : 26-04-2015 Notice of Annual General Meeting
11:38a ASR LOGISTICS : 26-04-2015 Proxy Form
11:36a Deutsche Bank first-quarter profit falls by half as legal charges bite
11:33a NABLE COMMUNICATIONS : Greenbrier East students are getting hands-on to help those in great need
11:29aDJDeutsche Bank Profit Halves on Litigation Costs -- Update
11:26a Deutsche Bank first quarter profit falls by half as legal charges bite
11:20a MOODY : Strong fundamentals PH ticket to 'A' ratings
11:13a TRANS CENTURY : Transcentury Posts Sh2.28 Billion Full-Year Loss
11:13a EURO BERHAD : FM Meets Permanent Envoys of Eastern European Countries in New York
Latest news
Advertisement
Hot News 
GCP STUDENT LIVING : Dividend Declaration and Net Asset Valuation
AERIE PHARMACEUTICALS : Pharma plunges aftermarket as Rhopressa study fails
SYQIC : Gets Working Capital Facility Offer, Improves Cash Position
INNATE PHARMA : and AstraZeneca announce global agreement for IPH2201 in immuno-oncology
French Connection warns on full-year results
Most Read News
04/25 DEUTSCHE BANK : to keep 500 German retail branches - Welt am Sonntag
04/25 MANCHESTER UNITED : United aiming to win title next year
04/25 KROGER : accounting celebrates 20 years of growth in Hutchinson
05:27aDJGOOGLE : Correction to Mount Everest Avalanche Story
04/25 SOLARCITY : Town of Plattsburgh exploring solar project
Most recommended articles
11:36a Deutsche Bank first-quarter profit falls by half as legal charges bite
10:24a Serbia seals deal with Abu Dhabi developer for controversial Belgrade makeover
10:00aDJNokia Quells Speculation Over Return to Mobile-Device Manufacturing
09:46aDJENI : Strike Shuts Down Key Eni Field in Libya
09:12aDJUnited Spirits Board Members Demand Resignation of Chairman Vijay Mallya
Dynamic quotes  
ON
| OFF